All In Biotech

Drug Trial Radar · NCT00327691

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

The Effect Of LDL-Cholesterol, Lowering Beyond Currently Recommended Minimum Targets On Coronary Heart Disesse (CHD) Recurrence In Patients With Pre-Existing CHD

Last checked: Nov 19, 2026Latest source record: May 3, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 8,600 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

8,600

Actual

Start

Apr 1998

Primary completion

Not stated

Study completion Aug 2004

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
May 18, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Prevention
Who can join
All sexes, from 35 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to determine the degree of additional reduction in cardiovascular risk that was accrued to patients by lowering their LDL-C beyond the currently accepted minimum target level for patients with pre-existing CHD. Secondary objectives include the safety profile of this treatment strategy, its cost-effectiveness, effect on other atherosclerotic-related events and procedures, and total mortality.

Conditions

  • Cardiovascular Disease
  • Cerebrovascular Accident
  • Coronary Heart Disease

Interventions

  • AtorvastatinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary outcome is the time to occurrence of a major
  2. cardiovascular event, defined as the composite outcome of the
  3. following clinical endpoints
  4. CHD death
  5. Non-fatal/Non-procedure related MI
  6. Resuscitated cardiac arrest or fatal/non-fatal stroke

Locations

314 sites in 14 countries. Site status is shown where the registry gives one.

  • Pfizer Investigational Site

    Alabaster, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Hoover, Alabama

  • Pfizer Investigational Site

    Montgomery, Alabama

  • Pfizer Investigational Site

    Mesa, Arizona

  • Pfizer Investigational Site

    Mesa, Arizona

  • Pfizer Investigational Site

    Burbank, California

  • Pfizer Investigational Site

    Camp Pendleton, California

  • Pfizer Investigational Site

    Fresno, California

  • Pfizer Investigational Site

    La Jolla, California

  • Pfizer Investigational Site

    Loma Linda, California

  • Pfizer Investigational Site

    Los Angeles, California

  • Pfizer Investigational Site

    Los Angeles, California

  • Pfizer Investigational Site

    Modesto, California

  • Pfizer Investigational Site

    Pasadena, California

  • Pfizer Investigational Site

    Rancho Mirage, California

  • Pfizer Investigational Site

    San Diego, California

  • Pfizer Investigational Site

    San Francisco, California

  • Pfizer Investigational Site

    San Francisco, California

  • Pfizer Investigational Site

    Santa Rosa, California

  • Pfizer Investigational Site

    Stanford, California

  • Pfizer Investigational Site

    Aurora, Colorado

  • Pfizer Investigational Site

    Denver, Colorado

  • Pfizer Investigational Site

    Denver, Colorado

  • Pfizer Investigational Site

    Denver, Colorado

  • Pfizer Investigational Site

    Bridgeport, Connecticut

  • Pfizer Investigational Site

    Hartford, Connecticut

  • Pfizer Investigational Site

    New Britain, Connecticut

  • Pfizer Investigational Site

    Newark, Delaware

  • Pfizer Investigational Site

    Washington D.C., District of Columbia

  • Pfizer Investigational Site

    Clearwater, Florida

  • Pfizer Investigational Site

    Gainsville, Florida

  • Pfizer Investigational Site

    Gainsville, Florida

  • Pfizer Investigational Site

    Hollywood, Florida

  • Pfizer Investigational Site

    Inverness, Florida

  • Pfizer Investigational Site

    Lakeland, Florida

  • Pfizer Investigational Site

    Miami, Florida

  • Pfizer Investigational Site

    Miami, Florida

Showing 40 of 314 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.